South Korea Car-T Cell Therapy Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

South Korea Car-T Cell Therapy Market is Segmented By Targeted Antigen (CD19, CD20, BCMA, GCP-3, Claudin 18.2), By Therapeutic Application (B-cell non-Hodgkin\'s lymphoma, Multiple Myeloma, Cervical Cancer, Gastric Cancer, Lung Cancer, Others). The report offers the value (in USD Million) for the above-mentioned segments

South Korea Car-T Cell Therapy Market is Segmented By Targeted Antigen (CD19, CD20, BCMA, GCP-3, Claudin 18.2), By Therapeutic Application (B-cell non....

South Korea Car-T Cell Therapy Market Leaders

Novartis AG
Pfizer, Inc.
Bristol Myers Squibb
CARsgen Therapeutics Co., Ltd.
Fate Therapeutics, Inc.

*Disclaimer: Major players are listed in no particular order.

South Korea Car-T Cell Therapy Market - Company List

Novartis AG
Pfizer, Inc.
Bristol Myers Squibb
CARsgen Therapeutics Co., Ltd.
Fate Therapeutics, Inc.
Poseida Therapeutics, Inc.
Eureka Therapeutics, Inc.
Johnson & Johnson
Cellular Biomedicine Group
Gilead Sciences, Inc.

South Korea Car-T Cell Therapy Market Report Snapshots

Buy Now